PUBLISHER: The Business Research Company | PRODUCT CODE: 1942535
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942535
Cataract surgery devices encompass instruments utilized in the treatment of cataracts, a condition where the lens of the eye progressively becomes opaque, leading to blurred vision.
The main types of cataract surgery devices and equipment include intraocular lens (IOL), ophthalmic viscoelastic device (OVD), phacoemulsification equipment, and femtosecond laser equipment. Ophthalmic viscoelastic devices (OVDs) are specifically employed in cataract surgeries. These devices and equipment are applied in various surgery types, including extracapsular cataract extraction, phacoemulsification, femtosecond laser procedures, among others. End-users of these devices include ophthalmology centers, hospitals, and clinics.
Tariffs are impacting the cataract surgery devices and equipment market by increasing costs of imported optical components, laser systems, precision instruments, and electronic modules used in phacoemulsification and femtosecond laser platforms. Hospitals and ophthalmology centers in North America and Europe are most affected due to reliance on imported surgical equipment, while Asia-Pacific faces higher production input costs. These tariffs are increasing procedure costs and capital investment requirements. However, they are also encouraging localized manufacturing, regional supplier partnerships, and innovation in cost-optimized cataract surgery solutions.
The cataract surgery devices and equipment market research report is one of a series of new reports from The Business Research Company that provides cataract surgery devices and equipment market statistics, including cataract surgery devices and equipment industry global market size, regional shares, competitors with a cataract surgery devices and equipment market share, detailed cataract surgery devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cataract surgery devices and equipment industry. This cataract surgery devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cataract surgery devices and equipment market size has grown steadily in recent years. It will grow from $14.52 billion in 2025 to $15.02 billion in 2026 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to increasing aging population, rising prevalence of cataract conditions, expansion of ophthalmic surgical facilities, growing acceptance of minimally invasive eye surgery, availability of advanced surgical instruments.
The cataract surgery devices and equipment market size is expected to see steady growth in the next few years. It will grow to $17.2 billion in 2030 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to increasing demand for customized intraocular lenses, rising adoption of laser-assisted cataract surgery, expansion of ambulatory ophthalmology centers, growing investments in eye care infrastructure, technological advancements in surgical visualization systems. Major trends in the forecast period include increasing adoption of premium and multifocal iols, rising use of femtosecond laser-assisted surgery, growing demand for advanced phacoemulsification systems, expansion of outpatient cataract surgery centers, enhanced focus on surgical precision and outcomes.
The growing geriatric population is projected to drive the expansion of the cataract surgery devices and equipment market in the coming years. The geriatric population includes individuals aged 65 years and above. As people age, they are more susceptible to developing cataracts, which increases demand for cataract surgery devices due to age-related vision impairment. As a result, the expanding elderly population has led to a higher requirement for cataract surgery procedures and associated equipment. For example, in January 2024, the Population Reference Bureau (PRB), a US-based private non-profit organization, reported that the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, reflecting a 47% increase. In addition, this age group's share of the total population is projected to increase from 17% to 23%. This trend highlights a pronounced aging pattern within the U.S. population. These projections underscore the growing need to address the requirements of older adults across multiple sectors. Therefore, the increasing geriatric population is contributing to the growth of the cataract surgery devices and equipment market.
Major companies in the cataract surgery devices and equipment market are focused on developing innovative products, such as the VERITAS Vision System, to enhance surgical accuracy and outcomes. The VERITAS Vision System is a next-generation phacoemulsification system designed to prioritize patient safety, surgeon efficiency, and comfort. For instance, in February 2024, Johnson & Johnson, a US-based pharmaceutical and medical technology company, launched the Tecnis PureSee intraocular lens (IOL). The TECNIS PureSee IOL features a unique, purely refractive design that delivers consistent, high-quality vision with excellent contrast and low-light performance, comparable to that of monofocal IOLs. Cataract surgery is the most commonly performed surgery globally, with around 28 million procedures conducted annually. However, only 10-15% of patients receive advanced optical IOLs designed to address astigmatism and presbyopia. Surgeons and patients often face trade-offs when selecting an IOL, such as balancing clear vision at all distances against the potential for glares or halos. The TECNIS PureSee IOL aims to mitigate these concerns, improving overall outcomes for both patients and surgeons.
In July 2023, Vantage Surgical Solutions, specializing in mobilized surgical solutions, acquired Ophthalmic Surgical Solutions (OSS) for an undisclosed amount. This strategic acquisition aims to expand Vantage Surgical Solutions' ophthalmic surgical equipment and services portfolio, enhancing both product offerings and geographic reach. OSS, as a specialized company in ophthalmic surgical equipment and services, aligns with Vantage Surgical Solutions' focus on ophthalmic surgery access.
Major companies operating in the cataract surgery devices and equipment market are Alcon Inc, Bausch + Lomb Inc, Carl Zeiss Meditec AG, HOYA Corporation, NIDEK Co Ltd, STAAR Surgical Company, Rayner, Oculentis, Asico, Medennium, Sight Sciences, Lumenis, Katalyst Surgical, Visionix, Moria Surgical, SIFI S.p.A, Appasamy Associates, Biotech Healthcare Group, Omni Lens Pvt Ltd, Altacor, Bohus BioTech AB, CIMA Technology Inc, i-Medical Ophthalmic International Heidelberg GmbH, Medisonic Equipments Pvt Ltd, OPTIKON SpA, Meda Co Ltd, Ziemer Ophthalmic Systems AG, HumanOptics AG, Hanita Lenses Ltd, Lenstec Inc, CRISTALENS SL, OPHTEC BV, Aurolab Co
North America was the largest region in the global cataract surgery devices and equipment market in 2025. Asia-Pacific was the second-largest region in cataract surgery devices and equipment market. The regions covered in the cataract surgery devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cataract surgery devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cataract surgery devices and equipment market consist of sales of ophthalmic viscoelastic devices, phacoemulsification equipment, and femtosecond laser equipment that are used for the cataract surgery. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cataract Surgery Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cataract surgery devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cataract surgery devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cataract surgery devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.